Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Genworth Financial Inc Common Stock (GNW) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance

Genworth Financial Inc Common StockTrade
uniQure N.V. Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

Genworth Financial Inc Common Stock vs uniQure N.V. Ordinary Shares — how do they compare? Genworth Financial Inc Common Stock trades at $8.82 (market cap $3.36B), while uniQure N.V. Ordinary Shares trades at $20.78 (market cap $1.48B). The key difference: Genworth Financial Inc Common Stock is far larger — about 2.3× uniQure N.V. Ordinary Shares's market cap, and Genworth Financial Inc Common Stock is trading nearer its 52-week high, uniQure N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Genworth Financial Inc Common Stock for 0 Days and uniQure N.V. Ordinary Shares for 0 Days on average.

GNWQURE
Market Cap
$3.36B$1.48B
Volume
3,333,1562,488,780
Sector
FinancialsHealth
52-Week High
$10.60$70.59
52-Week Low
$7.94$9.03
Typical Hold Time
0 Days0 Days
Enterprise Value
$2.87B$728.62M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Genworth Financial Inc Common Stock

Genworth Financial (GNW) trades at $8.89, down 1.77% today, with neutral technical signals and mixed fundamental performance. The company maintains stable revenue around $7.1-7.2B but faces margin pressure, with net income declining from $223M to $212M year-over-year. Recent Q2 2026 earnings beat expectations at $0.29 EPS, while the company expanded its share repurchase program by $500M in September 2026.

GNW presents value characteristics with low P/B (0.38) and P/S (0.49) ratios, but weak profitability metrics (ROE 2.42%) and analyst caution (70.59% hold rating) suggest limited near-term catalysts. Key risks include legacy insurance liabilities and competitive pressures, while the upcoming Q3 earnings on November 4 could provide directional clarity.

uniQure N.V. Ordinary Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GNW
100% Buy0% Sell
Avg holding period · 0 Days
QURE
100% Buy0% Sell
Avg holding period · 0 Days

About Genworth Financial Inc Common Stock

Genworth Financial, Inc. is a holding company that provides products and services related to aging and long-term care planning, and is the parent company of publicly traded mortgage insurer Enact Holdings, Inc.

Read more on GNW →

About uniQure N.V. Ordinary Shares

uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.

Read more on QURE →